EMERGENT BIOSOLUT
EMERGENT BIOSOLUT operates in Diversified Metals & Mining.
EMERGENT BIOSOLUT (ER4) - Total Assets
Latest total assets as of June 2024: €1.51 Billion EUR
Based on the latest financial reports, EMERGENT BIOSOLUT (ER4) holds total assets worth €1.51 Billion EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
EMERGENT BIOSOLUT - Total Assets Trend (2016–2023)
This chart illustrates how EMERGENT BIOSOLUT’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
EMERGENT BIOSOLUT - Asset Composition Analysis
Current Asset Composition (December 2023)
EMERGENT BIOSOLUT's total assets of €1.51 Billion consist of 37.3% current assets and 62.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 6.1% |
| Accounts Receivable | €141.80 Million | 7.8% |
| Inventory | €328.90 Million | 18.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €566.60 Million | 31.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how EMERGENT BIOSOLUT's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EMERGENT BIOSOLUT's current assets represent 37.3% of total assets in 2023, a decrease from 52.6% in 2016.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2023, down from 28.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, an increase from 7.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 31.1% of total assets.
EMERGENT BIOSOLUT Competitors by Total Assets
Key competitors of EMERGENT BIOSOLUT based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
EMERGENT BIOSOLUT - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - EMERGENT BIOSOLUT generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - EMERGENT BIOSOLUT is currently not profitable relative to its asset base.
EMERGENT BIOSOLUT - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.06 | 1.12 | 2.54 |
| Quick Ratio | 0.54 | 0.61 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €34.80 Million | € 84.50 Million | € 424.70 Million |
EMERGENT BIOSOLUT - Advanced Valuation Insights
This section examines the relationship between EMERGENT BIOSOLUT's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -42.4% |
| Total Assets | €1.82 Billion |
| Market Capitalization | $96.32K USD |
Valuation Analysis
Below Book Valuation: The market values EMERGENT BIOSOLUT's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: EMERGENT BIOSOLUT's assets decreased by 42.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for EMERGENT BIOSOLUT (2016–2023)
The table below shows the annual total assets of EMERGENT BIOSOLUT from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €1.82 Billion | -42.42% |
| 2022-12-31 | €3.17 Billion | +7.05% |
| 2021-12-31 | €2.96 Billion | +2.58% |
| 2020-12-31 | €2.88 Billion | +23.89% |
| 2019-12-31 | €2.33 Billion | +4.39% |
| 2018-12-31 | €2.23 Billion | +108.32% |
| 2017-12-31 | €1.07 Billion | +10.32% |
| 2016-12-31 | €970.11 Million | -- |